Viewing Study NCT04996758


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-01-05 @ 2:44 PM
Study NCT ID: NCT04996758
Status: COMPLETED
Last Update Posted: 2024-12-12
First Post: 2021-08-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module